Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Hung

Showing results (191-200 of 562) with videos related to

Pageof 57
Sort By:
Journal of Food and Drug Analysis|December 12, 2024
Camphorataimide B suppresses the metastasis of human colorectal cancer cell by inhibiting Smad/FAK/Akt axis and promoting degradation of Snail/BMP4 complexChi-Chou Huang, Chia-Hung Hung, Yi-Ju Lee, et al.
BMC Cancer|August 29, 2023
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinomaYen-Hao Chen, Ching-Hua Tsai, Yen-Yang Chen, et al.
The American Journal of Gastroenterology|October 3, 2002
Comparison of prevalence for paraumbilical vein patency in patients with viral and alcoholic liver cirrhosisChien-Hung Chen, Jing-Houng Wang, Sheng-Nan Lu, et al.
BMC Cancer|December 4, 2019
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resectionMing-Chao Tsai, Yi-Hao Yen, Kuo-Chin Chang, et al.
The Kaohsiung Journal of Medical Sciences|August 21, 2019
Liver stiffness measurement at complete virological response in hepatoma prediction for HBV-related cirrhosis patient with potent antiviral agentJing-Houng Wang, Tsung-Hui Hu, Chien-Hung Chen, et al.
Cancers|October 27, 2022
A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral TherapyChien-Hung Chen, Tsung-Hui Hu, Jing-Houng Wang, et al.
Digestive Diseases and Sciences|August 17, 2022
Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir CessationShao-Ming Chiu, Kuo-Chin Chang, Tsung-Hui Hu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 7, 2006
Small hepatic nodules (< or =2 cm) in cirrhosis patients: characterization with contrast-enhanced ultrasonographyJing-Houng Wang, Sheng-Nan Lu, Chao-Hung Hung, et al.
Bioscience, Biotechnology, and Biochemistry|January 11, 2007
Genomic and cDNA cloning, characterization of Delonix regia trypsin inhibitor (DrTI) gene, and expression of DrTI in Escherichia coliChih-Hung Hung, Pei-Hua Peng, Chou-Chun Huang, et al.
Journal of Gastroenterology and Hepatology|April 28, 2005
Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infectionChao-Hung Hung, Chuan-Mo Lee, Sheng-Nan Lu, et al.
Pageof 57

Showing results (191-200 of 562) with videos related to

Sort By:
Pageof 57
Journal of Food and Drug Analysis|December 12, 2024
Camphorataimide B suppresses the metastasis of human colorectal cancer cell by inhibiting Smad/FAK/Akt axis and promoting degradation of Snail/BMP4 complexChi-Chou Huang, Chia-Hung Hung, Yi-Ju Lee, et al.
BMC Cancer|August 29, 2023
Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinomaYen-Hao Chen, Ching-Hua Tsai, Yen-Yang Chen, et al.
The American Journal of Gastroenterology|October 3, 2002
Comparison of prevalence for paraumbilical vein patency in patients with viral and alcoholic liver cirrhosisChien-Hung Chen, Jing-Houng Wang, Sheng-Nan Lu, et al.
BMC Cancer|December 4, 2019
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resectionMing-Chao Tsai, Yi-Hao Yen, Kuo-Chin Chang, et al.
The Kaohsiung Journal of Medical Sciences|August 21, 2019
Liver stiffness measurement at complete virological response in hepatoma prediction for HBV-related cirrhosis patient with potent antiviral agentJing-Houng Wang, Tsung-Hui Hu, Chien-Hung Chen, et al.
Cancers|October 27, 2022
A Mac-2 Binding Protein Glycosylation Isomer-Based Risk Model Predicts Hepatocellular Carcinoma in HBV-Related Cirrhotic Patients on Antiviral TherapyChien-Hung Chen, Tsung-Hui Hu, Jing-Houng Wang, et al.
Digestive Diseases and Sciences|August 17, 2022
Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir CessationShao-Ming Chiu, Kuo-Chin Chang, Tsung-Hui Hu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 7, 2006
Small hepatic nodules (< or =2 cm) in cirrhosis patients: characterization with contrast-enhanced ultrasonographyJing-Houng Wang, Sheng-Nan Lu, Chao-Hung Hung, et al.
Bioscience, Biotechnology, and Biochemistry|January 11, 2007
Genomic and cDNA cloning, characterization of Delonix regia trypsin inhibitor (DrTI) gene, and expression of DrTI in Escherichia coliChih-Hung Hung, Pei-Hua Peng, Chou-Chun Huang, et al.
Journal of Gastroenterology and Hepatology|April 28, 2005
Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infectionChao-Hung Hung, Chuan-Mo Lee, Sheng-Nan Lu, et al.
Pageof 57